{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:29:52Z","timestamp":1793694592034,"version":"4.5.1"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772606"],"award-info":[{"award-number":["2025M772606"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108450","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:22:35Z","timestamp":1789662155000},"page":"108450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Challenges and strategies of non-coding RNA therapies in addressing tumor heterogeneity in head and neck cancers"],"prefix":"10.1016","volume":"233","author":[{"given":"Xiaohan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40265-023-01835-2","article-title":"Treating head and neck cancer in the age of immunotherapy: a 2023 update","volume":"83","author":"Bhatia","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","article-title":"Targeted therapy for head and neck cancer: signaling pathways and clinical studies","volume":"8","author":"Li","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108450_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2017.09.026","article-title":"NUDT21 regulates 3\u2032-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma","volume":"410","author":"Sun","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108450_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fgene.2020.00064","article-title":"Post-transcriptional dysregulation of microRNA and alternative polyadenylation in colorectal cancer","volume":"11","author":"Mao","year":"2020","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/hmg\/ddae176","article-title":"Constructing methylation-driven ceRNA networks unveil tumor heterogeneity and predict patient prognosis","volume":"34","author":"Li","year":"2025","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10238-025-01903-9","article-title":"Cuproptosis in lung cancer: a nexus of ncRNA regulation, epigenetics, and tumor microenvironment Remodeling","volume":"26","author":"Imam","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib8","first-page":"681","article-title":"miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology","volume":"28","author":"Koz\u0142owska-Mas\u0142o\u0144","year":"2023","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"15","key":"10.1016\/j.phrs.2026.108450_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153752","article-title":"Non-coding RNAs in oral cancer: emerging roles and clinical applications","volume":"15","author":"Dey","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.phrs.2026.108450_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10059-013-2154-7","article-title":"MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells","volume":"35","author":"Kim","year":"2013","journal-title":"Mol. Cells"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib12","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047662","article-title":"miRNA interplay: mechanisms and consequences in cancer","volume":"14","author":"Hill","year":"2021","journal-title":"Dis. Model. Mech."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of microRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2026.108450_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hed.21356","article-title":"Potential role of micro-RNAs in head and neck tumorigenesis","volume":"32","author":"Tran","year":"2010","journal-title":"Head. Neck"},{"issue":"18","key":"10.1016\/j.phrs.2026.108450_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00086-19","article-title":"MicroRNA (miRNA)-to-miRNA regulation of programmed cell death 4 (PDCD4)","volume":"39","author":"Ajuyah","year":"2019","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib16","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3892\/or.2014.3456","article-title":"miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines","volume":"32","author":"Sun","year":"2014","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2026.108450_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109929","article-title":"Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene","volume":"9","author":"Ou","year":"2014","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.canep.2014.07.008","article-title":"A let-7 microRNA polymorphism in the KRAS 3\u2032-UTR is prognostic in oropharyngeal cancer","volume":"38","author":"De Ruyck","year":"2014","journal-title":"Cancer Epidemiol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23834","article-title":"Let-7 reduces the proliferation and migration of oral cancer cells via PI3K\/AKT signaling pathway","volume":"38","author":"Liu","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.phrs.2026.108450_bib20","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.12659\/MSM.908628","article-title":"Role of Lin28A\/let-7a\/c-Myc pathway in growth and malignant behavior of papillary thyroid carcinoma","volume":"24","author":"Huang","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jop.12711","article-title":"Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8","volume":"47","author":"Peng","year":"2018","journal-title":"J. Oral. Pathol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/138920207781386933","article-title":"Enjoy the silence: the story of let-7 microRNA and cancer","volume":"8","author":"J\u00e9r\u00f4me","year":"2007","journal-title":"Curr. Genom."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2009.11.093","article-title":"miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion","volume":"391","author":"Xia","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12964-019-0490-8","article-title":"The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation","volume":"17","author":"Yu","year":"2019","journal-title":"Cell. Commun. Signal."},{"issue":"35","key":"10.1016\/j.phrs.2026.108450_bib25","doi-asserted-by":"crossref","first-page":"57254","DOI":"10.18632\/oncotarget.11138","article-title":"miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108450_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1476-4598-13-184","article-title":"miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis","volume":"13","author":"Cheung","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2026.108450_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2559.2012.04242.x","article-title":"Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck","volume":"61","author":"Odar","year":"2012","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4161\/cc.11.4.19228","article-title":"MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN","volume":"11","author":"Qu","year":"2012","journal-title":"Cell. Cycle"},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib29","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.18632\/oncotarget.3165","article-title":"The miR-491-3p\/mTORC2\/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer","volume":"6","author":"Zheng","year":"2015","journal-title":"Oncotarget"},{"issue":"7381","key":"10.1016\/j.phrs.2026.108450_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1474","article-title":"Genetic variants in mRNA untranslated regions","volume":"9","author":"Steri","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib32","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/cas.14394","article-title":"FNDC3B 3\u2032-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci."},{"issue":"22","key":"10.1016\/j.phrs.2026.108450_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225573","article-title":"Mechanisms and functions of long non-coding RNAs at multiple regulatory levels","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib34","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1038\/s41598-024-57987-y","article-title":"Investigating diagnostic potential of long non-coding RNAs in head and neck squamous cell carcinoma using TCGA database and clinical specimens","volume":"14","author":"Lan","year":"2024","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/2211-5463.70042","article-title":"Long non-coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application","volume":"15","author":"Tran","year":"2025","journal-title":"FEBS Open. Bio"},{"issue":"2","key":"10.1016\/j.phrs.2026.108450_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1139\/bcb-2019-0497","article-title":"Long non-coding RNA AWPPH enhances malignant phenotypes in nasopharyngeal carcinoma via silencing PTEN through interacting with LSD1 and EZH2","volume":"99","author":"Guo","year":"2021","journal-title":"Biochem. Cell. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib37","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3892\/ijo.2015.2976","article-title":"Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma","volume":"46","author":"Wu","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"30","key":"10.1016\/j.phrs.2026.108450_bib38","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1021\/jacs.4c05205","article-title":"Deciphering the temporal-spatial interactive heterogeneity of long non-coding RNAs and RNA-binding proteins in living cells at single-cell resolution","volume":"146","author":"Yang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12935-024-03302-8","article-title":"LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma","volume":"24","author":"Rong","year":"2024","journal-title":"Cancer Cell. Int."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","article-title":"Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2","volume":"61","author":"Redis","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108450_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.782216","article-title":"Identification and validation of 17-lncRNA related to regulatory t cell heterogeneity as a prognostic signature for head and neck squamous cell carcinoma","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13040798","article-title":"lncRNA EGOT is the marker of HPV infection and a prognostic factor for HNSCC patients","volume":"13","author":"Kolenda","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108450_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146133","article-title":"RNA polyadenylation patterns in the human transcriptome","volume":"816","author":"Xu","year":"2022","journal-title":"Gene"},{"issue":"7441","key":"10.1016\/j.phrs.2026.108450_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.phrs.2026.108450_bib45","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-20-4321","article-title":"Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1","volume":"81","author":"Ge","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib46","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/0008-5472.CAN-22-2585","article-title":"circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.108450_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.782439","article-title":"Circular RNAs are potential prognostic markers of head and neck squamous cell carcinoma: findings of a meta-analysis study","volume":"12","author":"Nath","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41420-024-02053-9","article-title":"Crosstalk between CAFs and tumour cells in head and neck cancer","volume":"10","author":"Li","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.phrs.2026.108450_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218015","article-title":"Cancer stem cell mechanisms and targeted therapeutic strategies in head and neck squamous cell carcinoma","volume":"634","author":"Maharajan","year":"2025","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108450_bib51","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1158\/0008-5472.CAN-23-0748","article-title":"Spatial profiling of circular RNAs in cancer reveals high expression in muscle and stromal cells","volume":"83","author":"Garc\u00eda-Rodr\u00edguez","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13059-019-1701-8","article-title":"Detection of circular RNA expression and related quantitative trait loci in the human dorsolateral prefrontal cortex","volume":"20","author":"Liu","year":"2019","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.molcel.2017.10.034","article-title":"The output of protein-coding genes shifts to circular RNAs when the pre-mRNA processing machinery is limiting","volume":"68","author":"Liang","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108450_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.humgen.2025.201469","article-title":"A systems biology approach to uncover CNV-driven lncRNA regulatory networks in HPV-associated head and neck squamous cell carcinoma","volume":"46","author":"Agrawal","year":"2025","journal-title":"Human Gene"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7150\/ijms.35133","article-title":"Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines","volume":"17","author":"Lepore","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib56","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/cas.15281","article-title":"HPV(+) HNSCC-derived exosomal miR-9-5p inhibits TGF-\u03b2 signaling-mediated fibroblast phenotypic transformation through NOX4","volume":"113","author":"Wang","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib57","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41467-025-56150-z","article-title":"Intratumor heterogeneity of HPV integration in HPV-associated head and neck cancer","volume":"16","author":"Sasa","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41588-023-01357-3","article-title":"Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma","volume":"55","author":"Puram","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib59","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","article-title":"EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib60","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1038\/s41467-024-52981-4","article-title":"Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma","volume":"15","author":"Ge","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41598-018-19341-x","article-title":"Integrated miRNA-mRNA spatial signature for oral squamous cell carcinoma: a prospective profiling study of Narrow Band Imaging guided resection","volume":"8","author":"Farah","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108450_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.006","article-title":"Small extracellular vesicles containing miR-192\/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma","volume":"506","author":"Zhu","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib64","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","article-title":"Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/msp2.44","article-title":"Hypoxia combined with radiation reverses migration and invasion of head and neck squamous cell carcinoma by remodeling","volume":"1","author":"Chuanshi","year":"2024","journal-title":"Malig. Spectr."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108450_bib67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/thno.87329","article-title":"Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p","volume":"14","author":"Kang","year":"2024","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/carcin\/bgy006","article-title":"A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF\/interleukin-33","volume":"39","author":"Ding","year":"2018","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00018-024-05210-6","article-title":"Tumor-associated macrophage-derived exosomal miR21-5p promotes tumor angiogenesis by regulating YAP1\/HIF-1\u03b1 axis in head and neck squamous cell carcinoma","volume":"81","author":"Yan","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib70","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1166\/jbn.2021.3066","article-title":"Macrophage-derived exosomal miR-31-5p promotes oral squamous cell carcinoma tumourigenesis through the large tumor suppressor 2-mediated hippo signalling pathway","volume":"17","author":"Yuan","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib71","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/odi.15212","article-title":"TAM-derived exosomes promote EMT by upregulating lncRNA MIR4435-2HG in head and neck cancer","volume":"31","author":"Liu","year":"2025","journal-title":"Oral. Dis."},{"issue":"24","key":"10.1016\/j.phrs.2026.108450_bib72","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1111\/jcmm.17998","article-title":"Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages","volume":"27","author":"Wu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108450_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112742","article-title":"M2 Macrophage exosomal HOXC13-AS in laryngeal cancer immunity via targeting miR-485-5p\/IGF2BP2\/PD-L1","volume":"140","author":"He","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib74","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091849","article-title":"Activation of matrix hyaluronan-mediated CD44 signaling, epigenetic regulation and chemoresistance in head and neck cancer stem cells","volume":"18","author":"Bourguignon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108450_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.651692","article-title":"MiRNA-146a\/AKT\/\u03b2-catenin activation regulates cancer stem cell phenotype in oral squamous cell carcinoma by targeting CD24","volume":"11","author":"Ghuwalewala","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jop.13405","article-title":"lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p\/PDK1","volume":"52","author":"Li","year":"2023","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.phrs.2026.108450_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1795813","article-title":"LUCAT1 promotes stemness in head and neck squamous cell carcinoma by sponging miR-128","volume":"16","author":"Wen","year":"2026","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","article-title":"miRNA Deregulation in cancer cells and the tumor microenvironment","volume":"6","author":"Rupaimoole","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib80","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12903-022-02425-6","article-title":"MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1\u03b1 expression","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Oral. Health"},{"issue":"10","key":"10.1016\/j.phrs.2026.108450_bib81","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/mc.22674","article-title":"Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma","volume":"56","author":"Zhu","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-021-01440-5","article-title":"Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications","volume":"21","author":"He","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib83","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib84","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nantod.2015.06.008","article-title":"15 years on siRNA delivery: beyond the state-of-the-art on inorganic nanoparticles for RNAi therapeutics","volume":"10","author":"Conde","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.phrs.2026.108450_bib85","first-page":"218","article-title":"Intranasal delivery of targeted polyfunctional gold\u2013iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide","author":"Sukumar","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108450_bib86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biomaterials.2015.01.065","article-title":"Micron-sized iron oxide-containing particles for microRNA-targeted manipulation and MRI-based tracking of transplanted cells","volume":"51","author":"Leder","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108450_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119693","article-title":"Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA","volume":"588","author":"Campani","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2026.108450_bib88","series-title":"Delivery of Therapeutic miRNA Using Polymer-based Formulation","author":"Ban","year":"2019"},{"issue":"25","key":"10.1016\/j.phrs.2026.108450_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/app.48651","article-title":"Polymer nanocarriers for MicroRNA delivery","volume":"137","author":"Kapadia","year":"2019","journal-title":"J. Appl. Polym. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gt.2016.71","article-title":"A brief account of viral vectors and their promise for gene therapy","volume":"24","author":"Finer","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2026.108450_bib91","first-page":"9","article-title":"Gene therapy leaves a vicious cycle","author":"Goswami","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108450_bib92","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/cbt.9.7.11267","article-title":"Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells","volume":"9","author":"Ma","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108450_bib93","first-page":"160","article-title":"MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest","volume":"310","author":"Xu","year":"2011","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.phrs.2026.108450_bib94","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrg2628","article-title":"Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications","volume":"10","author":"Brown","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib95","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib96","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156652311795684740","article-title":"Current advances in retroviral gene therapy","volume":"11","author":"Yi","year":"2011","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib97","article-title":"Retroviral gene therapy: safety issues and possible solutions","volume":"5","author":"Youngsuk Yi","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.phrs.2026.108450_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics","author":"Kay","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108450_bib99","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7150\/thno.33482","article-title":"Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib101","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New technologies for analysis of extracellular vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib103","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/mt.2013.54","article-title":"Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis","volume":"21","author":"El-Sayed","year":"2013","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108450_bib104","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2004.10.004","article-title":"Nuclear delivery of macromolecules: barriers and carriers","volume":"57","author":"Belting","year":"2005","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"30","key":"10.1016\/j.phrs.2026.108450_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202312153","article-title":"Nanoplatform-based in vivo gene delivery systems for cancer therapy","volume":"20","author":"Luo","year":"2024","journal-title":"Small"},{"issue":"13","key":"10.1016\/j.phrs.2026.108450_bib107","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1093\/nar\/gkm480","article-title":"Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers","volume":"35","author":"Yu","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.phrs.2026.108450_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213725","article-title":"SNPs in 3\u2032UTR miRNA target sequences associated with individual drug susceptibility","volume":"23","author":"Rykova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108450_bib109","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.omtn.2023.08.005","article-title":"Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression","volume":"33","author":"Huang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2026.108450_bib110","article-title":"APADB: a database for alternative polyadenylation and microRNA regulation events","volume":"2014","author":"M\u00fcller","year":"2014","journal-title":"Database (Oxf. )"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108450_bib112","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fgene.2019.00933","article-title":"Comprehensive analysis of human microRNA-mRNA interactome","volume":"10","author":"Plotnikova","year":"2019","journal-title":"Front. Genet."},{"issue":"7209","key":"10.1016\/j.phrs.2026.108450_bib113","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108450_bib114","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2026.108450_bib115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/DDDT.S288859","article-title":"The Risks of miRNA therapeutics: in a drug target perspective","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug. Des. Devel Ther."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040911","article-title":"MicroRNAs as emerging regulators of signaling in the tumor microenvironment","volume":"12","author":"Syed","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib117","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12885-025-13965-9","article-title":"Role of cancer associated fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review","volume":"25","author":"Golestannejad","year":"2025","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib118","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1007\/s13277-015-4402-2","article-title":"Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs","volume":"37","author":"Mao","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib119","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12967-025-06486-3","article-title":"Advances in tumor subclone formation and mechanisms of growth and invasion","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"McGranahan","year":"2015","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1078-0432.CCR-17-2410","article-title":"Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection","volume":"24","author":"Niehr","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108450_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101251","article-title":"MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3K\u03b1 inhibitors of head & neck squamous cell carcinoma","volume":"81","author":"Pulito","year":"2025","journal-title":"Drug. Resist. Updat."},{"issue":"5-6","key":"10.1016\/j.phrs.2026.108450_bib123","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10495-023-01832-6","article-title":"Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma","volume":"28","author":"Xu","year":"2023","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.phrs.2026.108450_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of microRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri1351","article-title":"Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation","volume":"4","author":"Ley","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib126","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2096","article-title":"The role of junctional adhesion molecules in vascular inflammation","volume":"7","author":"Weber","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2613.2003.00235.x","article-title":"Role of cell adhesion molecules in leukocyte recruitment in the liver and gut","volume":"84","author":"Ala","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108450_bib128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1369\/jhc.2008.951061","article-title":"Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon","volume":"56","author":"Kikuchi","year":"2008","journal-title":"J. Histochem. Cytochem."},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1096\/fj.03-1110fje","article-title":"Tenascin-C and SF\/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac","volume":"18","author":"De Wever","year":"2004","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib130","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1263412","article-title":"The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200","volume":"6","author":"Noman","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib131","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.18632\/oncotarget.14374","article-title":"Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages","volume":"8","author":"Takahashi","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.phrs.2026.108450_bib132","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108450_bib133","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.trecan.2018.10.002","article-title":"The multiple layers of the tumor environment","volume":"4","author":"Laplane","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib134","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.phrs.2026.108450_bib135","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.7150\/thno.45164","article-title":"PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer","volume":"10","author":"Lo","year":"2020","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.phrs.2026.108450_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70170","article-title":"TMTP1-modified small extracellular vesicles target BRAF mutation in anaplastic thyroid cancer reversing vemurafenib resistance with CRISPR\/Cas9 delivery","volume":"14","author":"Zhang","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"5-6","key":"10.1016\/j.phrs.2026.108450_bib137","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jgm.2770","article-title":"Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer","volume":"16","author":"Jung","year":"2014","journal-title":"J. Gene Med."},{"key":"10.1016\/j.phrs.2026.108450_bib138","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.oraloncology.2018.05.013","article-title":"Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial","volume":"82","author":"Siano","year":"2018","journal-title":"Oral. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib139","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-023-01468-8","article-title":"Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study","volume":"16","author":"Tassone","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108450_bib140","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1039\/C9NR01122F","article-title":"Photoacoustic-imaging-guided therapy of functionalized melanin nanoparticles: combination of photothermal ablation and gene therapy against laryngeal squamous cell carcinoma","volume":"11","author":"Fan","year":"2019","journal-title":"Nanoscale"},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib141","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2012.67","article-title":"Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma","volume":"20","author":"Piao","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108450_bib142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.oraloncology.2017.07.004","article-title":"Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo","volume":"72","author":"Alexander-Bryant","year":"2017","journal-title":"Oral. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108450_bib143","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.phrs.2026.108450_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213716","article-title":"Progress in precision medicine for head and neck cancer","volume":"16","author":"Vakili","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.phrs.2026.108450_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158257","article-title":"Promising biomarkers in head and neck cancer: the most clinically important miRNAs","volume":"23","author":"Thomaidou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib146","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jds.2021.08.017","article-title":"A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma","volume":"17","author":"Zhang","year":"2022","journal-title":"J. Dent. Sci."},{"key":"10.1016\/j.phrs.2026.108450_bib147","article-title":"A five-microRNA signature predicts the prognosis in nasopharyngeal carcinoma","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","article-title":"Single-cell RNA sequencing in cancer research","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib149","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170019","article-title":"SNPs in microRNA target sites and their potential role in human disease","volume":"7","author":"Moszy\u0144ska","year":"2017","journal-title":"Open Biol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108450_bib150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tig.2008.07.004","article-title":"MicroRNA target site polymorphisms and human disease","volume":"24","author":"Sethupathy","year":"2008","journal-title":"Trends Genet."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib151","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170019","article-title":"SNPs in microRNA target sites and their potential role in human disease","volume":"7","author":"Moszy\u0144ska","year":"2017","journal-title":"Open. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108450_bib152","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/annonc\/mdv100","article-title":"A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer","volume":"26","author":"Lee","year":"2015","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108450_bib153","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ccell.2025.07.008","article-title":"Circulating tumor cells: blood-based detection, molecular biology, and clinical applications","volume":"43","author":"Dai","year":"2025","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.phrs.2026.108450_bib154","article-title":"Understanding tumor heterogeneity: Implications for precision oncology and therapeutic strategies","volume":"1881","author":"Lv","year":"2026","journal-title":"Biochimica et Biophys. Acta (BBA) - Rev. Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2026.108450_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105904","article-title":"Whole-exome ctDNA sequencing reveals intratumoral heterogeneity and drivers of relapse in locally advanced head and neck cancer","volume":"10","author":"Bruixola","year":"2025","journal-title":"ESMO Open."},{"key":"10.1016\/j.phrs.2026.108450_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.107011","article-title":"Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma","volume":"158","author":"Payne","year":"2024","journal-title":"Oral. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib157","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-025-00874-z","article-title":"From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening","volume":"14","author":"Luo","year":"2025","journal-title":"Biomarker Res."},{"key":"10.1016\/j.phrs.2026.108450_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100297","article-title":"Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances","volume":"8","author":"Velpula","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib159","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12967-019-1986-0","article-title":"Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108450_bib160","article-title":"Lipid nanoparticle-based delivery of small interfering RNAs: New possibilities in the treatment of diverse diseases","volume":"223","author":"Askarizadeh","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"0","key":"10.1016\/j.phrs.2026.108450_bib161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IJN.S429279","article-title":"Advancing therapeutic strategies with polymeric drug conjugates for nucleic acid delivery and treatment","volume":"20","author":"Ullah","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.phrs.2026.108450_bib162","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1039\/D4NR05371K","article-title":"vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology","volume":"17","author":"Schock Vaiani","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2026.108450_bib163","article-title":"Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy","volume":"15 - 2024","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108450_bib164","first-page":"205","article-title":"Scaffolds functionalized with matrix metalloproteinase-responsive release of miRNA for synergistic magnetic hyperthermia and sensitizing chemotherapy of drug-tolerant breast cancer","volume":"44","author":"Sun","year":"2025","journal-title":"Bioact. Mater."},{"issue":"04","key":"10.1016\/j.phrs.2026.108450_bib165","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BST20253010","article-title":"Redesigning miR-34a: structural and chemical advances in the therapeutic development of an miRNA anti-cancer agent","volume":"53","author":"Iyer","year":"2025","journal-title":"Biochem. Soc. Trans."},{"issue":"39","key":"10.1016\/j.phrs.2026.108450_bib166","doi-asserted-by":"crossref","first-page":"18274","DOI":"10.1039\/D4NR02795G","article-title":"Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer","volume":"16","author":"Patni","year":"2024","journal-title":"Nanoscale"},{"issue":"30","key":"10.1016\/j.phrs.2026.108450_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202400837","article-title":"Target reprogramming the 3\u2032UTR of tumor-suppressor genes by a siRNA composite nanoparticle for glioblastoma therapy","volume":"34","author":"Gu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.phrs.2026.108450_bib168","article-title":"A biomimetic dual-targeting nano-APA-editor reprograms the 3\u2032UTR landscape for tongue squamous cell carcinoma therapy","author":"Ao","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.phrs.2026.108450_bib169","article-title":"DGCR8\/miR-106 axis enhances radiosensitivity of head and neck squamous cell carcinomas by downregulating RUNX3","volume":"7 - 2020","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.phrs.2026.108450_bib170","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1002\/jcb.29008","article-title":"Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2026.108450_bib171","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jconrel.2021.07.034","article-title":"Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles","volume":"337","author":"Kampel","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.108450_bib172","article-title":"CricRNA in head and neck squamous cell carcinoma: biological functions and clinical prospects","volume":"15","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108450_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148321","article-title":"Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction","volume":"910","author":"Wang","year":"2024","journal-title":"Gene"},{"issue":"21","key":"10.1016\/j.phrs.2026.108450_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215273","article-title":"miR766-3p and miR124-3p dictate drug resistance and clinical outcome in HNSCC","volume":"14","author":"Shibata","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/mt.2015.169","article-title":"Nanoparticle delivered VEGF-A siRNA enhances photodynamic therapy for head and neck cancer treatment","volume":"24","author":"Lecaros","year":"2016","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108450_bib176","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.21873\/anticanres.14235","article-title":"MALAT1 Decreases the sensitivity of head and neck squamous cell carcinoma cells to radiation and cisplatin","volume":"40","author":"Kangboonruang","year":"2020","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.phrs.2026.108450_bib177","article-title":"The role and targeting strategies of non-coding RNAs in immunotherapy resistance in oral squamous cell carcinoma","volume":"13 - 2025","author":"Liang","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108450_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2024.07.1665","article-title":"Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy","volume":"120","author":"Held","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.phrs.2026.108450_bib179","doi-asserted-by":"crossref","first-page":"31454","DOI":"10.1038\/s41598-024-83184-y","article-title":"Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma","volume":"14","author":"Yin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108450_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2026.152540","article-title":"Single-cell sequencing in pan-cancer research: decoding heterogeneity, tumor microenvironment, and clinical translation","author":"Lu","year":"2026","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.phrs.2026.108450_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.73.e173259","article-title":"Non-coding RNAs in gene therapy: mechanisms, delivery strategies, and clinical translation","volume":"73","author":"Abuhaliema","year":"2026","journal-title":"PHARMACIA"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:12:25Z","timestamp":1793693545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":181,"alternative-id":["S1043661826003658"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108450","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and strategies of non-coding RNA therapies in addressing tumor heterogeneity in head and neck cancers","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108450"}}